These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hydrogel Loaded with Components for Therapeutic Applications in Hypertrophic Scars and Keloids. Zhong Y; Zhang Y; Lu B; Deng Z; Zhang Z; Wang Q; Zhang J Int J Nanomedicine; 2024; 19():883-899. PubMed ID: 38293605 [TBL] [Abstract][Full Text] [Related]
24. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Tredget EE; Nedelec B; Scott PG; Ghahary A Surg Clin North Am; 1997 Jun; 77(3):701-30. PubMed ID: 9194888 [TBL] [Abstract][Full Text] [Related]
25. Inflammation in Wound Healing and Pathological Scarring. Hong YK; Chang YH; Lin YC; Chen B; Guevara BEK; Hsu CK Adv Wound Care (New Rochelle); 2023 May; 12(5):288-300. PubMed ID: 36541356 [No Abstract] [Full Text] [Related]
26. Keloids: current concepts of pathogenesis (review). Bran GM; Goessler UR; Hormann K; Riedel F; Sadick H Int J Mol Med; 2009 Sep; 24(3):283-93. PubMed ID: 19639219 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical Evaluation of Leptin Expression in Wound Healing: A Clue to Exuberant Scar Formation. Seleit I; Bakry OA; Samaka RM; Tawfik AS Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):296-306. PubMed ID: 26258753 [TBL] [Abstract][Full Text] [Related]
28. Insights into the Pathophysiology of Hypertrophic Scars and Keloids: How Do They Differ? Ghazawi FM; Zargham R; Gilardino MS; Sasseville D; Jafarian F Adv Skin Wound Care; 2018 Jan; 31(1):582-595. PubMed ID: 29240586 [TBL] [Abstract][Full Text] [Related]
29. Wnt Signaling Pathway Proteins in Scar, Hypertrophic Scar, and Keloid: Evidence for a Continuum? Chaudet KM; Goyal A; Veprauskas KR; Nazarian RM Am J Dermatopathol; 2020 Nov; 42(11):842-847. PubMed ID: 32310858 [TBL] [Abstract][Full Text] [Related]
31. Insights into the Pathophysiology of Hypertrophic Scars and Keloids: How Do They Differ? Adv Skin Wound Care; 2018 Jan; 31(1):E1. PubMed ID: 29240593 [No Abstract] [Full Text] [Related]
32. Hypertrophic and keloid scars fail to progress from the CD34 Limandjaja GC; Belien JM; Scheper RJ; Niessen FB; Gibbs S Br J Dermatol; 2020 Apr; 182(4):974-986. PubMed ID: 31206605 [TBL] [Abstract][Full Text] [Related]
33. Management of scar contractures, hypertrophic scars, and keloids. Sherris DA; Larrabee WF; Murakami CS Otolaryngol Clin North Am; 1995 Oct; 28(5):1057-68. PubMed ID: 8559572 [TBL] [Abstract][Full Text] [Related]
34. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids. Amadeu TP; Braune AS; Porto LC; Desmoulière A; Costa AM Wound Repair Regen; 2004; 12(2):169-74. PubMed ID: 15086768 [TBL] [Abstract][Full Text] [Related]
35. New insights on keloids, hypertrophic scars, and striae. Ud-Din S; Bayat A Dermatol Clin; 2014 Apr; 32(2):193-209. PubMed ID: 24680006 [TBL] [Abstract][Full Text] [Related]
36. Surgical considerations in skin of colour: minimizing pathological scars. Obi EE Clin Exp Dermatol; 2022 Aug; 47(8):1429-1437. PubMed ID: 35187688 [TBL] [Abstract][Full Text] [Related]
37. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis. Amadeu T; Braune A; Mandarim-de-Lacerda C; Porto LC; Desmoulière A; Costa A Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263 [TBL] [Abstract][Full Text] [Related]
39. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405 [TBL] [Abstract][Full Text] [Related]
40. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Slemp AE; Kirschner RE Curr Opin Pediatr; 2006 Aug; 18(4):396-402. PubMed ID: 16914994 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]